Guo Q - Search Results

1

Dysfunction of chaperone-mediated autophagy in human diseases.

Liao Z, Wang B, Liu W, Xu Q, Hou L, Song J, Guo Q, Li N. Liao Z, et al. Among authors: guo q. Mol Cell Biochem. 2021 Mar;476(3):1439-1454. doi: 10.1007/s11010-020-04006-z. Epub 2021 Jan 3. Mol Cell Biochem. 2021. PMID: 33389491 Review.

2

TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating TP53.

Yang J, Wang B, Xu Q, Yang Y, Hou L, Yin K, Guo Q, Hua Y, Zhang L, Li Y, Zhang J, Li N. Yang J, et al. Among authors: guo q. Mol Cell Biochem. 2021 Feb;476(2):1151-1163. doi: 10.1007/s11010-020-03979-1. Epub 2020 Nov 16. Mol Cell Biochem. 2021. PMID: 33200377

3

Bispecific antibody activated T cells: A newly developed T cells with enhanced proliferation ability and cytotoxicity.

Guo Q, Zhang Z, Zhao P, Zou S, Li L, Li N, Sun W, Wei X, Hou L, Yang Z, Gao D. Guo Q, et al. Immunol Lett. 2020 Apr;220:79-87. doi: 10.1016/j.imlet.2019.12.010. Epub 2019 Dec 31. Immunol Lett. 2020. PMID: 31901377

4

TIM-3 blockade combined with bispecific antibody MT110 enhances the anti-tumor effect of γδ T cells.

Guo Q, Zhao P, Zhang Z, Zhang J, Zhang Z, Hua Y, Han B, Li N, Zhao X, Hou L. Guo Q, et al. Cancer Immunol Immunother. 2020 Dec;69(12):2571-2587. doi: 10.1007/s00262-020-02638-0. Epub 2020 Jun 25. Cancer Immunol Immunother. 2020. PMID: 32588076 Free PMC article.

5

Gemcitabine treatment enhanced the anti-tumor effect of cytokine induced killer cells by depletion of CD4⁺CD25^bri regulatory T cells.

Zhao P, Zhu D, Zhang Z, Han B, Gao D, Wei X, Xie X, Li C, Sun W, Wang Q, Guo Q. Zhao P, et al. Among authors: guo q. Immunol Lett. 2017 Jan;181:36-44. doi: 10.1016/j.imlet.2016.11.009. Epub 2016 Nov 17. Immunol Lett. 2017. PMID: 27867030

6

Dendritic Cells Therapy with Cytokine-Induced Killer Cells and Activated Cytotoxic T Cells Attenuated Th2 Bias Immune Response.

Li C, Zhu D, Zhao Y, Guo Q, Sun W, Li L, Gao D, Zhao P. Li C, et al. Among authors: guo q. Immunol Invest. 2020 Jul;49(5):522-534. doi: 10.1080/08820139.2019.1696360. Epub 2019 Dec 3. Immunol Invest. 2020. PMID: 31793363

7

EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab.

Yu L, Guo QM, Wang Y, Xu Y, Liu L, Zhang XT. Yu L, et al. J Thorac Dis. 2021 Apr;13(4):2404-2413. doi: 10.21037/jtd-21-442. J Thorac Dis. 2021. PMID: 34012588 Free PMC article.

8

Efficient killing of radioresistant breast cancer cells by cytokine-induced killer cells.

Guo Q, Zhu D, Bu X, Wei X, Li C, Gao D, Wei X, Ma X, Zhao P. Guo Q, et al. Tumour Biol. 2017 Mar;39(3):1010428317695961. doi: 10.1177/1010428317695961. Tumour Biol. 2017. PMID: 28349820 Free article.

9

Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer.

Zhao P, Bu X, Wei X, Sun W, Xie X, Li C, Guo Q, Zhu D, Wei X, Gao D. Zhao P, et al. Among authors: guo q. Int Immunopharmacol. 2015 Apr;25(2):450-6. doi: 10.1016/j.intimp.2015.02.010. Epub 2015 Feb 16. Int Immunopharmacol. 2015. PMID: 25698555 Clinical Trial.

10

[Study on Molecular Biology of Rare Two A307 Phenotypes].

Han B, Feng ZH, Guo QM, Wang MM. Han B, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Jun;24(3):918-20. doi: 10.7534/j.issn.1009-2137.2016.03.051. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 27342533 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,617 results

Search Page